Visiongain says “Digital Therapeutics market set to grow to over $1.3bn in 2017”

18 June 2018
Electronics

Visiongain has launched a new pharma report The Digital Therapeutics Market Forecast 2017-2027: Forecasts by Application (Diabetes, Obesity CVD, CNS, Respiratory) End-User, (Patients, Caregivers, Employers, Payers, Pharmaceutical Companies) and Geography

Visiongain has defined digital therapeutics as treatment options that includes various digital and health techniques to be used in treating people with medical or psychological conditions, in order to improve patient outcomes by helping encourage more beneficial patient behaviour. The Digital Therapeutics market is expected to register significant growth over the forecast period owing to an increase in demand for online healthcare activities and modernization of healthcare delivery in the future aimed at preventative healthcare.

The Digital Therapeutics market is segmented by application and end-user in this report. The application segment is further divided into six categories: diabetes, obesity, CVD, CNS, respiratory and other. The end-user segment is split into patients, caregivers, employers, payers and pharmaceutical companies. Furthermore, the study includes the market estimation, market forecast and market information for six geographical regions around the globe.

The lead Visiongain report analyst for this report commented: “A large proportion of manufacturers are focused towards novel innovation and introduction of technology that will provide the latest products in the global healthcare market. Governments, insurers, employers, general practitioners and specialists recognise that the key to meet the challenges of healthcare provision in the 21st Century is on the basis of digital technology, helping to promote preventative care to lessen the increasing burden on the world’s healthcare systems.”

The Digital Therapeutics market is highly competitive with many different players entering the market. The report discusses selected leading companies in the market. Notable companies in the global smart pill market Omada Health, Canary Health, Noom Inc., Livongo Health, WellDoc Inc., Propeller Health, Evolent Health, Doximity, Perfint Healthcare, and Proteus Digital Health Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Wearable Medical Devices market set to grow to $14.8bn by 2022” says Visiongain report

A rise in global healthcare costs coupled with increased awareness amongst consumers and expanding middle class population in developing countries have led to a sudden increase in demand for wearable medical devices.

18 June 2018

Read

Visiongain says “Digital Therapeutics market set to grow to over $1.3bn in 2017”

The Digital Therapeutics market is expected to register significant growth over the forecast period owing to an increase in demand for online healthcare activities and modernization of healthcare delivery in the future aimed at preventative healthcare.

18 June 2018

Read

“Industrial Control System market set to reach $126.2bn in 2018” states new Visiongain report

The fusion of Big Data, the Internet of Things, and advanced analytics is providing manufacturers with unprecedented insights into manufacturing performance, customer behaviour, and new product development as never seen before

18 June 2018

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
WOOCS 2.2.1